Answers are grounded in this paper and cite their sources.
QFT-Plus has diagnostic performance that is very similar to that of QFT-GIT. Further studies are needed to assess the sensitivity of QFT-Plus in immunocompromised patients and younger children before concluding if this new version offers advantages.
No takes yet. Share an insight, caveat, or question.
Oh et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: